Effectiveness of weight management interventions for people with serious mental illness who receive treatment with atypical antipsychotic medications. A literature review

Journal of Psychiatric and Mental Health Nursing

Volumn 15, Issue 10, 2008, Pages 857-863

  Lowe, T ^a   Lubos, E ^b  

^a UNIVERSITY OF WEST LONDON   (United Kingdom)

^b OXFORD HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Medication management; Mental health; Psychosis; Psychotropic medications

Indexed keywords

ANTIDEPRESSANT AGENT;

CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DIABETES MELLITUS; DRUG EFFECT; EXERCISE; HUMAN; MENTAL DISEASE; PHYSIOLOGY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; EXERCISE; HUMANS; MENTAL DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 55349125688     PISSN: 13510126     EISSN: 13652850     Source Type: Journal    
DOI: 10.1111/j.1365-2850.2008.01337.x     Document Type: Review

References (31)

1. Archie S.M., Goldberg J.O., Akhtaqr-Danesh N., et al. (2007) Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes? Psychiatric Services 58, 233 239.
2. Ball M.P., Coons V.B. Buchanan R.W. (2001) A programme for treating Olanzapine related weight gain. Psychiatric Services 52, 967 969.
3. Bradshaw T., Lovell K. Harris N. (2005) Healthy living interventions and schizophrenia: a systematic review. Journal of Advanced Nursing 49, 634 654.
4. Brar J.S., Ganguli R., Pandina G., et al. (2005) Effects of behavioural therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. Journal of Clinical Psychiatry 66, 205 212.
5. Brown S. (1997) Excess mortality experiences of individuals on the Salford Psychiatric case register: I All cause mortality. British Journal of Psychiatry 168, 772 779.
6. Brown S., Birthwistle J., Roe L., et al. (1999) The unhealthy lifestyle of people with schizophrenia. Psychological Medicine 29, 679 701.
7. Centorrino F., Wurtman J.J., Duca K.A., et al. (2006) Weight loss in overweight patients maitained on atypical antipsychotic agents. International Journal of Obesity 30, 1011 1016.
8. Dean J., Todd G., Morrow H., et al. (2001) Mum, I used to be good looking. Look at me now: the physical health needs of adults with mental health problems: the perspective of users, carers and front line staff. International Journal of Mental Health Promotion 3, 16 24.
9. Dembling B.P., Chen D.T., Vachon L. (1999) Life expectancy and causes of death in a population treated for serious mental illness. Psychiatric Services 50, 1036 1042.
10. Department of Health (DOH) (2006) Care Pathway for the Management of Overweight and Obesity. DOH, London.
11. Department of Health (DOH) (2007) A Guide to Receiving Local Payments from Your Local Council: A Route to Independent Living. DOH, London.
12. Dickey B., Normand S., Weiss R., et al. (2002) Medical morbidity, mental illness and substance use disorders. Psychiatric Services 53, 861 867.
13. Eisenberg M.E., Neumark-Sztainer D. Story M. (2003) Associations of weight-based teasing and emotional well-being among adolescents. Archives of Paediatrics and Adolescent Medicine 157, 733 738.
14. Evans S., Newton S. Higgins S. (2005) Nutritional intervention to prevent weight gain in patients commenced on Olanzapine: a randomized controlled trial. Australian and New Zealand Journal of Psychiatry 39, 479 486.
15. Faulkner G., Soundy A.A. Lloyd K. (2003) Schizophrenia and weight management: a systematic review of interventions to control weight. Acta Psychiatrica Scandinavica 108, 324 332.
16. Faulkner G., Cohn T. Remington G. (2006) Interventions to Reduce Weight Gain in Schizophrenia. The Cochrane Library, Chichester.
17. Hart C. (2001) Doing a Literature Search. A Comprehensive Guide for the Social Sciences. Sage Publications, London.
18. Jun S.K., Choi J.S., Bahk W.M., et al. (2006) Weight management program for treatment emergent weight gain in Olanzapine treated patents with schizophrenia or schizoaffective disorder: a 12 week randomized controlled clinical trail. Journal of Clinical Psychiatry 67, 547 553.
19. Littrell K.H., Hilligoss N.M., Kirshner C.D., et al. (2003) The effects of an educational intervention on antipsychotic-induced weight gain. Journal of Nursing Scholarship 35, 237 241.
20. Menza M., Vreeland B., Minsky S., et al. (2004) Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Journal of Clinical Psychiatry 65, 471 477.
21. Nasrallah H.A. (2008) Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Molecular Psychiatry 13, 27 35.
22. National Institute for Health and Clinical Excellence (NICE) (2002) Schizophrenia. Full National Clinical Guideline on Core Interventions in Primary and Secondary Care. British Psychological Society and Geskell, London.
23. National Institute for Health and Clinical Excellence (NICE) (2006a) Bipolar Disorder. The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. British Psychological Society and Royal College of Psychiatrists, London.
24. National Institute for Health and Clinical Excellence (NICE) (2006b) Obesity Guidance on Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. National Institute for Health and Clinical Excellence and National Collaborating Centre for Primary Care, London.
25. Pendlebury J., Bushe C.J., Wildgust H.J., et al. (2007) Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK. Acta Psychiatrica Scandinavica 115, 286 294.
26. Stathopolou G., Powers M., Berry A., et al. (2006) Exercise interventions for mental health: a qualitative and quantitative review. Clinical Psychology and Practice 13, 179 193.
27. Taylor D., Paton C. Kerwin R. (2005) The South London & Maudsley NHS Trust & Oxleas NHS Trust 2005-2006 Prescribing Guidelines, 8th edn. Taylor & Francis, London.
28. Tharoke J.H., Mann J.N., Vlahos I., et al. (2002) Increased visceral fat distribution in drug naïve and drug-free patients with schizophrenia. International Journal of Obesity 26, 137 141.
29. Ussher M., Stanbury L., Cheeseman V., et al. (2007) Physical activity preferences and perceived barriers to activity among persons with severe mental illness in the united kingdom. Psychiatric Services 58, 405 408.
30. Weber M. Wyne K. (2006) A cognitive behavioural group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research 83, 95 101.
31. Wu M.-K., Wang C.-K., Bai Y.-M., et al. (2007) Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity programme. Psychiatric Services 58, 544 550.